Blockade of CXCR3 with ACT-777991 monotherapy was not efficacious in inducing diabetes remission in both mouse models versus isotype-treated animals (data not shown for the RIP-LCMV-GP model). The gene discussed is CXCR3; the disease is diabetes mellitus.